Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |